AIM

(redirected from CD69)
Also found in: Dictionary, Thesaurus, Medical, Legal.
Related to CD69: CD25, CD44

AIM

(1) (AOL Instant Messenger) America Online's instant messaging service, which supports text chat, photo sharing, online gaming and PC to PC voice. An AIM list of Instant Messenger contacts is called a "Buddy List." AIM was part of America Online and then a stand-alone service in 1997. It was discontinued at the end of 2017. See instant messaging.

(2) (Application Integration Middleware) An umbrella term for middleware software that ties applications together. See application integration, middleware and PPMW.

(3) (Association for Automatic Identification and Mobility, Warrendale, PA, www.aimglobal.org) The trade association for the automatic identification and data capture (AIDC) industry. Established in 1982 as a product division of the Material Handling Institute (MHI), AIM is involved in setting standards for barcodes, magnetic stripes and RFID technology. See also AIIM.

(4) (Apple IBM Motorola) The alliance of Apple, IBM and Motorola that developed the PowerPC chip. See PowerPC and Apple-IBM alliance.
References in periodicals archive ?
Therefore, in this study, an attempt was made to examine the total peripheral blood NK cell count, CD69 activated NK cell count and NK cell cytotoxicity with the circulating levels of VEGF-A and VEGF-R1 in women with RIF to see if these may be related.
They are characterized by an activated memory state, as determined by CD69 and CD44 expression.
La activacion de las iNKT por las celulas dendriticas con CD1d-[alfa]GalCer da lugar a la expresion de CD69.
Furthermore, Groh et al also demonstrated that BMSCs-mediated inhibition of T cells was associated with the down regulation of their activation markers, CD25, CD38 and CD69 (8).
MGEB inhibited Con A-induced proliferation and the expression levels of cell surface molecules CD69 and CD25 of T cells in vitro.
have entered a biomarker services agreement under which Amarantus will evaluate the pharmacodynamic effect of a lead drug candidate combination on the expression of the biomarker CD69 using its Alzheimeris blood diagnostic LymPro Test.
Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGF-beta Expression.
Results showed that the expression of the marker CD69 on specific subpopulations of lymphocytic cells was statistically significantly lower in the AD groups versus the control group, as measured under two different stimulation conditions (LymPro Version 1 and LymPro Version 2).
Each case was assessed with antibodies directed against the following antigens: CD2, CD25, CD35, CD45, CD59, CD63, CD69, and CD117 (all from BD Biosciences).
We used a whole-blood CD69 lymphocyte-activation assay to determine whether study participants were infected with Coccidioides fungi; the assay methods used were similar to previously described methods (8-10).
Las celulas estimuladas y no estimuladas se resuspendieron en 200 [micron]l de amortiguador FACS (PBS pH 7,6; 1% SFB y 0,09% de azida de sodio), se agregaron los anticuerpos especificos contra los marcadores de superficie CD3 FITC, CD4 PercPe y CD69 APC (Becton Dickinson[R]), durante 15 minutos a 4 [grados]C en la oscuridad.